Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

22.07.2024

1 Am J Respir Crit Care Med
5 Ann Intern Med
1 Antiviral Res
10 BMJ
6 Clin Infect Dis
2 Int J Infect Dis
1 Intensive Care Med
5 J Infect
6 J Med Virol
1 J Travel Med
1 J Virol
1 JAMA
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Nature


    Am J Respir Crit Care Med

  1. ZIJLSTRA GJ
    Resilience and Stress Are Heterogenic Too: We Should Act Accordingly.
    Am J Respir Crit Care Med. 2024;210:245-246.
    >> Share


    Ann Intern Med


  2. Correction: Firearm Purchasing During the COVID-19 Pandemic.
    Ann Intern Med. 2024 Jul 16. doi: 10.7326/ANNALS-24-00962.
    >> Share

  3. KLOMPAS M, McKenna CS, Kanjilal S, Pak T, et al
    Morbidity and Mortality of Hospital-Onset SARS-CoV-2 Infections Due to Omicron Versus Prior Variants : A Propensity-Matched Analysis.
    Ann Intern Med. 2024 Jul 16. doi: 10.7326/M24-0199.
    >> Share

  4. CHOU R, Herman E, Ahmed A, Anderson J, et al
    Long COVID Definitions and Models of Care : A Scoping Review.
    Ann Intern Med. 2024;177:929-940.
    >> Share


  5. Annals Video Summary - Long COVID Definitions and Models of Care: A Scoping Review.
    Ann Intern Med. 2024;177:eM240874.
    >> Share

  6. BRODE WM
    Long COVID: The Enduring Pandemic.
    Ann Intern Med. 2024;177:978-979.
    >> Share


    Antiviral Res

  7. OLIVEIRA EH, Monteleone-Cassiano AC, Tavares L, Santos JC, et al
    A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19.
    Antiviral Res. 2024;229:105968.
    >> Share


    BMJ

  8. IACOBUCCI G
    Sixty seconds on . . . nasal sprays.
    BMJ. 2024;386:q1560.
    >> Share

  9. IACOBUCCI G
    Childhood immunisation: Global rates remain below pre-pandemic levels.
    BMJ. 2024;386:q1577.
    >> Share

  10. WISE J
    Covid-19: Progression to clinical type 1 diabetes accelerated after infection, study suggests.
    BMJ. 2024;386:q1557.
    >> Share

  11. MAGNUS MC, Soderling J, Ortqvist AK, Andersen AN, et al
    Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study.
    BMJ. 2024;386:e079364.
    >> Share

  12. LIMB M
    King's speech: Health leaders laud commitments on public and mental health as "game changing".
    BMJ. 2024;386:q1590.
    >> Share

  13. MAHASE E
    GPs in Wales need "urgent rescue package" after 100 practices close, says BMA.
    BMJ. 2024;386:q1589.
    >> Share

  14. MAHASE E
    Covid inquiry: UK government failed its citizens through "groupthink," poor planning, and widening inequalities.
    BMJ. 2024;386:q1602.
    >> Share


  15. Seven days in medicine: 10-16 July 2024.
    BMJ. 2024;386:q1566.
    >> Share

  16. MAHASE E
    GP appointment and patient record system disrupted by global IT outage.
    BMJ. 2024;386:q1617.
    >> Share

  17. LIMB M
    Paying care workers properly could cost pound40bn but would lead to NHS savings, says strategy.
    BMJ. 2024;386:q1608.
    >> Share


    Clin Infect Dis

  18. JILG N, Giganti MJ, Chew KW, Shaw-Saliba K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jul 17:ciae324. doi: 10.1093.
    >> Share

  19. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

  20. FAUST JS, Meyerowitz-Katz G
    Is Paxlovid Still Worth It?
    Clin Infect Dis. 2024;79:111-114.
    >> Share

  21. GREEN E, Marcelin JR
    Robust Performance Metrics for Assessing Equitable Clinical Trial Participant Enrollment: Can We Get There?
    Clin Infect Dis. 2024;79:148-150.
    >> Share

  22. CHEYNE A, Muchamore I, Tulunay H, Rojek A, et al
    Community Involvement in an Outbreak-One Year on for Mpox.
    Clin Infect Dis. 2024;79:278-280.
    >> Share

  23. CHERABIE JN, Hazra A
    Community-Informed Approach Remains Critical to Our Mpox Response.
    Clin Infect Dis. 2024;79:280-281.
    >> Share


    Int J Infect Dis

  24. SHOJI R, Fukuda K, Mizobuchi T, Arakawa Y, et al
    Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination.
    Int J Infect Dis. 2024 Jul 16:107170. doi: 10.1016/j.ijid.2024.107170.
    >> Share

  25. MI X, Zhang X, Dai Z, Yan X, et al
    Clinical characteristics and outcomes of lung transplantation in patients with severe COVID-19 infection: A systematic review and meta-analysis.
    Int J Infect Dis. 2024 Jul 16:107176. doi: 10.1016/j.ijid.2024.107176.
    >> Share


    Intensive Care Med

  26. BOERS LS, van Someren Greve F, van Hattem JM, de Brabander J, et al
    Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
    Intensive Care Med. 2024 Jul 17. doi: 10.1007/s00134-024-07529.
    >> Share


    J Infect

  27. BECHMAN K, Green A, Russell MD, Yang Z, et al
    The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19.
    J Infect. 2024 Jul 15:106227. doi: 10.1016/j.jinf.2024.106227.
    >> Share

  28. HU Y, Shi W, Meng Q, Yuan L, et al
    Detection of Bordetella spp. in children with pertussis-like illness from 2018 to 2024 in China.
    J Infect. 2024;89:106222.
    >> Share

  29. ANDREWS N, Osuntoki I, Stowe J, Kirsebom FCM, et al
    The impact of Covid-19 vaccine spring boosters on Covid-19 hospital admissions in England 2022/23.
    J Infect. 2024 Jul 10:106221. doi: 10.1016/j.jinf.2024.106221.
    >> Share

  30. AUDRAN R, Karoui O, Donnet L, Soumas V, et al
    Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
    J Infect. 2024 Jun 17:106205. doi: 10.1016/j.jinf.2024.106205.
    >> Share

  31. YANG C, Sun JY, Li XL, Cheng N, et al
    Emerging and re-emerging genotype 2c porcine epidemic diarrhoea virus with high pathogenicity in China.
    J Infect. 2024;89:106192.
    >> Share


    J Med Virol

  32. CENAT JM, Moshirian Farahi SMM, Dalexis RD, Caulley L, et al
    COVID-19 vaccine mistrust, health literacy, conspiracy theories, and racial discrimination among a representative ethnically diverse sample in Canada: The vulnerability of Arab, Asian, Black, and Indigenous peoples.
    J Med Virol. 2024;96:e29795.
    >> Share

  33. LI S, Bu J, Pan X, Li Q, et al
    SARS-CoV-2 envelope protein-derived extracellular vesicles act as potential media for viral spillover.
    J Med Virol. 2024;96:e29782.
    >> Share


  34. Correction to [A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus].
    J Med Virol. 2024;96:e29803.
    >> Share

  35. SHEN Z, Li Q, Wu J, Zhu D, et al
    Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study.
    J Med Virol. 2024;96:e29800.
    >> Share

  36. REINIG S, Kuo C, Wu CC, Huang SY, et al
    Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines.
    J Med Virol. 2024;96:e29793.
    >> Share

  37. GAY L, Madariaga Zarza S, Abou Atmeh P, Rouviere MS, et al
    Protective role of macrophages from maternal-fetal interface in unvaccinated coronavirus disease 2019 pregnant women.
    J Med Virol. 2024;96:e29819.
    >> Share


    J Travel Med

  38. RAJPUT V, Das R, Pramanik R, Nannaware K, et al
    Early Detection of KP.2 SARS-CoV-2 Variant using Wastewater-based Genomic Surveillance in Pune, Maharashtra, India.
    J Travel Med. 2024 Jul 17:taae097. doi: 10.1093.
    >> Share


    J Virol

  39. ZHANG L, Yu R, Wang L, Zhang Z, et al
    Serial cell culture passaging in vitro led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain.
    J Virol. 2024 Jul 16:e0064524. doi: 10.1128/jvi.00645.
    >> Share


    JAMA

  40. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    >> Share


    Lancet Infect Dis

  41. CHOI MH, Wan EYF, Wong ICK, Chan EWY, et al
    Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study.
    Lancet Infect Dis. 2024 Jul 15:S1473-3099(24)00353.
    >> Share

  42. AKINOSOGLOU K, Gogos C
    Antiviral therapy for patients with COVID-19: mix and match.
    Lancet Infect Dis. 2024 Jul 15:S1473-3099(24)00407.
    >> Share


    MMWR Morb Mortal Wkly Rep

  43. JONES CE, Yusuf N, Ahmed B, Kassogue M, et al
    Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:614-621.
    >> Share


    N Engl J Med

  44. MEISSNER HC, Kapogiannis BG, Wolfe DN
    Anticipating the Next Pandemic.
    N Engl J Med. 2024;391:196-199.
    >> Share

  45. XIE Y, Choi T, Al-Aly Z
    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211.
    >> Share

  46. HAMMOND J, Yunis C, Fountaine RJ, Luscan G, et al
    Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2024;391:224-234.
    >> Share


    Nature

  47. KUDIABOR H
    Long COVID lung damage linked to immune system response.
    Nature. 2024 Jul 18. doi: 10.1038/d41586-024-02352.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016